<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-03-01" modified="2020-10-07" version="221">
<accession>P24385</accession>
<accession>Q6LEF0</accession>
<name>CCND1_HUMAN</name>
<protein>
<recommendedName>
<fullName>G1/S-specific cyclin-D1</fullName>
</recommendedName>
<alternativeName>
<fullName>B-cell lymphoma 1 protein</fullName>
<shortName>BCL-1</shortName>
</alternativeName>
<alternativeName>
<fullName>BCL-1 oncogene</fullName>
</alternativeName>
<alternativeName>
<fullName>PRAD1 oncogene</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CCND1</name>
<name type="synonym">BCL1</name>
<name type="synonym">PRAD1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Nature" volume="350" first="512" last="515">
<title>A novel cyclin encoded by a bcl1-linked candidate oncogene.</title>
<authorList>
<person name="Motokura T."/>
<person name="Bloom T."/>
<person name="Kim H.G."/>
<person name="Jueppner H."/>
<person name="Ruderman J.V."/>
<person name="Kronenberg H.M."/>
<person name="Arnold A."/>
</authorList>
<dbReference type="PubMed" id="1826542"/>
<dbReference type="DOI" id="10.1038/350512a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Cell" volume="66" first="1197" last="1206">
<title>Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast.</title>
<authorList>
<person name="Lew D.J."/>
<person name="Dulic V."/>
<person name="Reed S.I."/>
</authorList>
<dbReference type="PubMed" id="1833066"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90042-w"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Cell" volume="65" first="691" last="699">
<title>Human D-type cyclin.</title>
<authorList>
<person name="Xiong Y."/>
<person name="Connolly T."/>
<person name="Futcher B."/>
<person name="Beach D."/>
</authorList>
<dbReference type="PubMed" id="1827756"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90100-d"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="4846" last="4853">
<title>Characterization of a candidate bcl-1 gene.</title>
<authorList>
<person name="Withers D.A."/>
<person name="Harvey R.C."/>
<person name="Faust J.B."/>
<person name="Melnyk O."/>
<person name="Carey K."/>
<person name="Meeker T.C."/>
</authorList>
<dbReference type="PubMed" id="1833629"/>
<dbReference type="DOI" id="10.1128/mcb.11.10.4846"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1994" name="Blood" volume="83" first="3689" last="3696">
<title>Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.</title>
<authorList>
<person name="Rimokh R."/>
<person name="Berger F."/>
<person name="Bastard C."/>
<person name="Klein B."/>
<person name="French M."/>
<person name="Archimbaud E."/>
<person name="Rouault J.-P."/>
<person name="Santa Lucia B."/>
<person name="Duret L."/>
<person name="Vuillaume M."/>
</authorList>
<dbReference type="PubMed" id="8204893"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2002-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Genes Chromosomes Cancer" volume="7" first="89" last="95">
<title>The PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.</title>
<authorList>
<person name="Motokura T."/>
<person name="Arnold A."/>
</authorList>
<dbReference type="PubMed" id="7687458"/>
<dbReference type="DOI" id="10.1002/gcc.2870070205"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-66</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="71" last="79">
<title>CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.</title>
<authorList>
<person name="Bates S."/>
<person name="Bonetta L."/>
<person name="McAllan D."/>
<person name="Parry D."/>
<person name="Holder A."/>
<person name="Dickson C."/>
<person name="Peters G."/>
</authorList>
<dbReference type="PubMed" id="8302605"/>
</citation>
<scope>INTERACTION WITH CDK4 AND CDK6</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="Blood" volume="88" first="674" last="681">
<title>Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.</title>
<authorList>
<person name="Chesi M."/>
<person name="Bergsagel P.L."/>
<person name="Brents L.A."/>
<person name="Smith C.M."/>
<person name="Gerhard D.S."/>
<person name="Kuehl W.M."/>
</authorList>
<dbReference type="PubMed" id="8695815"/>
</citation>
<scope>INVOLVEMENT IN MULTIPLE MYELOMA</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="847" last="862">
<title>New functional activities for the p21 family of CDK inhibitors.</title>
<authorList>
<person name="LaBaer J."/>
<person name="Garrett M.D."/>
<person name="Stevenson L.F."/>
<person name="Slingerland J.M."/>
<person name="Sandhu C."/>
<person name="Chou H.S."/>
<person name="Fattaey A."/>
<person name="Harlow E."/>
</authorList>
<dbReference type="PubMed" id="9106657"/>
<dbReference type="DOI" id="10.1101/gad.11.7.847"/>
</citation>
<scope>INTERACTION WITH CDK4 IN THE CCND1-CDK4-CDKN COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="12074" last="12079">
<title>Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286.</title>
<authorList>
<person name="Germain D."/>
<person name="Russell A."/>
<person name="Thompson A."/>
<person name="Hendley J."/>
</authorList>
<dbReference type="PubMed" id="10766840"/>
<dbReference type="DOI" id="10.1074/jbc.275.16.12074"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF THR-286 AND THR-288</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Nature" volume="430" first="226" last="231">
<title>Cyclin-dependent kinases regulate the antiproliferative function of Smads.</title>
<authorList>
<person name="Matsuura I."/>
<person name="Denissova N.G."/>
<person name="Wang G."/>
<person name="He D."/>
<person name="Long J."/>
<person name="Liu F."/>
</authorList>
<dbReference type="PubMed" id="15241418"/>
<dbReference type="DOI" id="10.1038/nature02650"/>
</citation>
<scope>FUNCTION OF CCND1-CDK4 COMPLEX IN SMAD PHOSPHORYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Biochem. J." volume="397" first="169" last="177">
<title>INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases.</title>
<authorList>
<person name="Liu W.D."/>
<person name="Wang H.W."/>
<person name="Muguira M."/>
<person name="Breslin M.B."/>
<person name="Lan M.S."/>
</authorList>
<dbReference type="PubMed" id="16569215"/>
<dbReference type="DOI" id="10.1042/bj20051669"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INSM1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Endocrinol." volume="198" first="29" last="39">
<title>Identification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcription.</title>
<authorList>
<person name="Wang H.W."/>
<person name="Muguira M."/>
<person name="Liu W.D."/>
<person name="Zhang T."/>
<person name="Chen C."/>
<person name="Aucoin R."/>
<person name="Breslin M.B."/>
<person name="Lan M.S."/>
</authorList>
<dbReference type="PubMed" id="18417529"/>
<dbReference type="DOI" id="10.1677/joe-08-0001"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INSM1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="5574" last="5581">
<title>Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.</title>
<authorList>
<person name="Zhang T."/>
<person name="Liu W.D."/>
<person name="Saunee N.A."/>
<person name="Breslin M.B."/>
<person name="Lan M.S."/>
</authorList>
<dbReference type="PubMed" id="19124461"/>
<dbReference type="DOI" id="10.1074/jbc.m808843200"/>
</citation>
<scope>INTERACTION WITH INSM1 AND CDK4</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="469" last="476">
<title>Suppression of cancer cell growth by promoting cyclin D1 degradation.</title>
<authorList>
<person name="Shan J."/>
<person name="Zhao W."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="19917254"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.10.018"/>
</citation>
<scope>INTERACTION WITH USP2</scope>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Nature" volume="459" first="722" last="725">
<title>F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage.</title>
<authorList>
<person name="Santra M.K."/>
<person name="Wajapeyee N."/>
<person name="Green M.R."/>
</authorList>
<dbReference type="PubMed" id="19412162"/>
<dbReference type="DOI" id="10.1038/nature08011"/>
</citation>
<scope>PHOSPHORYLATION AT THR-286</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF THR-286</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Biochim. Biophys. Acta" volume="1803" first="975" last="982">
<title>TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity.</title>
<authorList>
<person name="Kim H."/>
<person name="Kang M."/>
<person name="Lee S.A."/>
<person name="Kwak T.K."/>
<person name="Jung O."/>
<person name="Lee H.J."/>
<person name="Kim S.H."/>
<person name="Lee J.W."/>
</authorList>
<dbReference type="PubMed" id="20399237"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2010.04.001"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CDK4</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Cell Cycle" volume="10" first="3284" last="3299">
<title>NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.</title>
<authorList>
<person name="Mori T."/>
<person name="Ikeda D.D."/>
<person name="Fukushima T."/>
<person name="Takenoshita S."/>
<person name="Kochi H."/>
</authorList>
<dbReference type="PubMed" id="21952639"/>
<dbReference type="DOI" id="10.4161/cc.10.19.17176"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH UHRF2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-286</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="4166" last="4170">
<title>Crystal structure of human CDK4 in complex with a D-type cyclin.</title>
<authorList>
<person name="Day P.J."/>
<person name="Cleasby A."/>
<person name="Tickle I.J."/>
<person name="O'Reilly M."/>
<person name="Coyle J.E."/>
<person name="Holding F.P."/>
<person name="McMenamin R.L."/>
<person name="Yon J."/>
<person name="Chopra R."/>
<person name="Lengauer C."/>
<person name="Jhoti H."/>
</authorList>
<dbReference type="PubMed" id="19237565"/>
<dbReference type="DOI" id="10.1073/pnas.0809645106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-271 IN COMPLEX WITH WILD TYPE AND MUTANTS ALA-172; PHE-172 AND ASP-172 CDK4</scope>
</reference>
<comment type="function">
<text evidence="9 10 11 20">Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner.</text>
</comment>
<comment type="subunit">
<text evidence="6 10 11 12 13 15 16 17 18 20">Interacts with FBXO4 (By similarity). Interacts with either CDK4 or CDK6 protein kinase to form a serine/threonine kinase holoenzyme complex. The cyclin subunit imparts substrate specificity to the complex. Component of the ternary complex CCND1/CDK4/CDKN1B required for nuclear translocation and modulation of CDK4-mediated kinase activity. Interacts directly with CDKN1B. Interacts with UHRF2; the interaction ubiquitinates CCND1 and appears to occur independently of phosphorylation. Can form similar complexes with either CDKN1A or CDKN2A. Interacts with USP2. Interacts (via cyclin N-terminal domain) with INSM1 (via N-terminal region); the interaction competes with the binding of CCND1 to CDK4 during cell cycle progression and inhibits CDK4 activity. Interacts with CDK4; the interaction is prevented with the binding of CCND1 to INSM1 during cell cycle progression.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-994813">
<id>P30260</id>
<label>CDC27</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-375096">
<id>P24941</id>
<label>CDK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-295644">
<id>P11802</id>
<label>CDK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>36</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-295663">
<id>Q00534</id>
<label>CDK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-375077">
<id>P38936</id>
<label>CDKN1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-519280">
<id>P46527</id>
<label>CDKN1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-6162477">
<id>Q5XUX0</id>
<label>FBXO31</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-607682">
<id>O15379</id>
<label>HDAC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-2547810">
<id>Q16656</id>
<label>NRF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-625304">
<id>Q96PU4</id>
<label>UHRF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-10201595">
<id>Q96TE0</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-847225">
<id>P30285</id>
<label>Cdk4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375001">
<id>P24385</id>
</interactant>
<interactant intactId="EBI-3956409">
<id>Q62796</id>
<label>Ralbp1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16 20">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="20">Nucleus membrane</location>
</subcellularLocation>
<text evidence="20">Cyclin D-CDK4 complexes accumulate at the nuclear membrane and are then translocated to the nucleus through interaction with KIP/CIP family members.</text>
</comment>
<comment type="PTM">
<text evidence="14 15">Phosphorylation at Thr-286 by MAP kinases is required for ubiquitination and degradation following DNA damage. It probably plays an essential role for recognition by the FBXO31 component of SCF (SKP1-cullin-F-box) protein ligase complex.</text>
</comment>
<comment type="PTM">
<text evidence="6 14 15">Ubiquitinated, primarily as 'Lys-48'-linked polyubiquitination. Ubiquitinated by a SCF (SKP1-CUL1-F-box protein) ubiquitin-protein ligase complex containing FBXO4 and CRYAB. Following DNA damage it is ubiquitinated by some SCF (SKP1-cullin-F-box) protein ligase complex containing FBXO31. SCF-type ubiquitination is dependent on Thr-286 phosphorylation (By similarity). Ubiquitinated also by UHRF2 apparently in a phosphorylation-independent manner. Ubiquitination leads to its degradation and G1 arrest. Deubiquitinated by USP2; leading to its stabilization.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving CCND1 may be a cause of B-lymphocytic malignancy, particularly mantle-cell lymphoma (MCL). Translocation t(11;14)(q13;q32) with immunoglobulin gene regions. Activation of CCND1 may be oncogenic by directly altering progression through the cell cycle.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving CCND1 may be a cause of parathyroid adenomas. Translocation t(11;11)(q13;p15) with the parathyroid hormone (PTH) enhancer.</text>
</comment>
<comment type="disease" evidence="19">
<disease id="DI-02700">
<name>Multiple myeloma</name>
<acronym>MM</acronym>
<description>A malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia.</description>
<dbReference type="MIM" id="254500"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving CCND1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus.</text>
</comment>
<comment type="similarity">
<text evidence="21">Belongs to the cyclin family. Cyclin D subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BCL1ID36.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/ccnd1/"/>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=CCND1"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<dbReference type="EMBL" id="X59798">
<property type="protein sequence ID" value="CAA42470.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M74092">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M64349">
<property type="protein sequence ID" value="AAA52136.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M73554">
<property type="protein sequence ID" value="AAA58392.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z23022">
<property type="protein sequence ID" value="CAA80558.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019845">
<property type="protein sequence ID" value="AAV38648.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF511593">
<property type="protein sequence ID" value="AAM34300.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000076">
<property type="protein sequence ID" value="AAH00076.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001501">
<property type="protein sequence ID" value="AAH01501.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014078">
<property type="protein sequence ID" value="AAH14078.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC023620">
<property type="protein sequence ID" value="AAH23620.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC025302">
<property type="protein sequence ID" value="AAH25302.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L09054">
<property type="protein sequence ID" value="AAA36481.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8191.1"/>
<dbReference type="PIR" id="A38977">
<property type="entry name" value="A38977"/>
</dbReference>
<dbReference type="RefSeq" id="NP_444284.1">
<property type="nucleotide sequence ID" value="NM_053056.2"/>
</dbReference>
<dbReference type="PDB" id="2W96">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-271"/>
</dbReference>
<dbReference type="PDB" id="2W99">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1-271"/>
</dbReference>
<dbReference type="PDB" id="2W9F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=1-271"/>
</dbReference>
<dbReference type="PDB" id="2W9Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=16-271"/>
</dbReference>
<dbReference type="PDB" id="5VZU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="E/F=279-295"/>
</dbReference>
<dbReference type="PDB" id="6P8E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=19-267"/>
</dbReference>
<dbReference type="PDB" id="6P8F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A=19-267"/>
</dbReference>
<dbReference type="PDB" id="6P8G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=19-267"/>
</dbReference>
<dbReference type="PDB" id="6P8H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.19"/>
<property type="chains" value="A=19-267"/>
</dbReference>
<dbReference type="PDBsum" id="2W96"/>
<dbReference type="PDBsum" id="2W99"/>
<dbReference type="PDBsum" id="2W9F"/>
<dbReference type="PDBsum" id="2W9Z"/>
<dbReference type="PDBsum" id="5VZU"/>
<dbReference type="PDBsum" id="6P8E"/>
<dbReference type="PDBsum" id="6P8F"/>
<dbReference type="PDBsum" id="6P8G"/>
<dbReference type="PDBsum" id="6P8H"/>
<dbReference type="SMR" id="P24385"/>
<dbReference type="BioGRID" id="107067">
<property type="interactions" value="215"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2010">
<property type="entry name" value="Cyclin D1-CDK4 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2014">
<property type="entry name" value="Cyclin D1-CDK6 complex"/>
</dbReference>
<dbReference type="CORUM" id="P24385"/>
<dbReference type="DIP" id="DIP-123N"/>
<dbReference type="IntAct" id="P24385">
<property type="interactions" value="68"/>
</dbReference>
<dbReference type="MINT" id="P24385"/>
<dbReference type="STRING" id="9606.ENSP00000227507"/>
<dbReference type="BindingDB" id="P24385"/>
<dbReference type="ChEMBL" id="CHEMBL3610"/>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01169">
<property type="generic name" value="Arsenic trioxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB11718">
<property type="generic name" value="Encorafenib"/>
</dbReference>
<dbReference type="DrugCentral" id="P24385"/>
<dbReference type="iPTMnet" id="P24385"/>
<dbReference type="PhosphoSitePlus" id="P24385"/>
<dbReference type="BioMuta" id="CCND1"/>
<dbReference type="DMDM" id="116152"/>
<dbReference type="EPD" id="P24385"/>
<dbReference type="jPOST" id="P24385"/>
<dbReference type="MassIVE" id="P24385"/>
<dbReference type="PaxDb" id="P24385"/>
<dbReference type="PeptideAtlas" id="P24385"/>
<dbReference type="PRIDE" id="P24385"/>
<dbReference type="ProteomicsDB" id="54198"/>
<dbReference type="Antibodypedia" id="3660">
<property type="antibodies" value="1956 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="P24385">
<property type="antibodies" value="6 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="595"/>
<dbReference type="Ensembl" id="ENST00000227507">
<property type="protein sequence ID" value="ENSP00000227507"/>
<property type="gene ID" value="ENSG00000110092"/>
</dbReference>
<dbReference type="GeneID" id="595"/>
<dbReference type="KEGG" id="hsa:595"/>
<dbReference type="CTD" id="595"/>
<dbReference type="DisGeNET" id="595"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000110092.3"/>
<dbReference type="GeneCards" id="CCND1"/>
<dbReference type="HGNC" id="HGNC:1582">
<property type="gene designation" value="CCND1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000110092">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="CCND1"/>
<dbReference type="MIM" id="168461">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="254500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P24385"/>
<dbReference type="OpenTargets" id="ENSG00000110092"/>
<dbReference type="Orphanet" id="67038">
<property type="disease" value="B-cell chronic lymphocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="52416">
<property type="disease" value="Mantle cell lymphoma"/>
</dbReference>
<dbReference type="Orphanet" id="29073">
<property type="disease" value="Multiple myeloma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA75"/>
<dbReference type="eggNOG" id="KOG0656">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157816"/>
<dbReference type="HOGENOM" id="CLU_052190_0_0_1"/>
<dbReference type="InParanoid" id="P24385"/>
<dbReference type="KO" id="K04503"/>
<dbReference type="OMA" id="SCYRTTH"/>
<dbReference type="OrthoDB" id="1234739at2759"/>
<dbReference type="PhylomeDB" id="P24385"/>
<dbReference type="TreeFam" id="TF101004"/>
<dbReference type="PathwayCommons" id="P24385"/>
<dbReference type="Reactome" id="R-HSA-187577">
<property type="pathway name" value="SCF(Skp2)-mediated degradation of p27/p21"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214858">
<property type="pathway name" value="RMTs methylate histone arginines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75815">
<property type="pathway name" value="Ubiquitin-dependent degradation of Cyclin D"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849470">
<property type="pathway name" value="PTK6 Regulates Cell Cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853884">
<property type="pathway name" value="Transcriptional Regulation by VENTX"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8878166">
<property type="pathway name" value="Transcriptional regulation by RUNX2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8934593">
<property type="pathway name" value="Regulation of RUNX1 Expression and Activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951430">
<property type="pathway name" value="RUNX3 regulates WNT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951936">
<property type="pathway name" value="RUNX3 regulates p14-ARF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9634638">
<property type="pathway name" value="Estrogen-dependent nuclear events downstream of ESR-membrane signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9661069">
<property type="pathway name" value="Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)"/>
</dbReference>
<dbReference type="SignaLink" id="P24385"/>
<dbReference type="SIGNOR" id="P24385"/>
<dbReference type="BioGRID-ORCS" id="595">
<property type="hits" value="503 hits in 879 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CCND1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P24385"/>
<dbReference type="GeneWiki" id="Cyclin_D1"/>
<dbReference type="GenomeRNAi" id="595"/>
<dbReference type="Pharos" id="P24385">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P24385"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="P24385">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000110092">
<property type="expression patterns" value="Expressed in endometrium epithelium and 229 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P24385">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P24385">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000307">
<property type="term" value="C:cyclin-dependent protein kinase holoenzyme complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="LIFEdb"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017053">
<property type="term" value="C:transcription repressor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016538">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase regulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070064">
<property type="term" value="F:proline-rich region binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030968">
<property type="term" value="P:endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045444">
<property type="term" value="P:fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007595">
<property type="term" value="P:lactation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033327">
<property type="term" value="P:Leydig cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060749">
<property type="term" value="P:mammary gland alveolus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033598">
<property type="term" value="P:mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044772">
<property type="term" value="P:mitotic cell cycle phase transition"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031571">
<property type="term" value="P:mitotic G1 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071157">
<property type="term" value="P:negative regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045737">
<property type="term" value="P:positive regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900087">
<property type="term" value="P:positive regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010971">
<property type="term" value="P:positive regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033601">
<property type="term" value="P:positive regulation of mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000320">
<property type="term" value="P:re-entry into mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000079">
<property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051412">
<property type="term" value="P:response to corticosterone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010039">
<property type="term" value="P:response to iron ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044321">
<property type="term" value="P:response to leptin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032026">
<property type="term" value="P:response to magnesium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010243">
<property type="term" value="P:response to organonitrogen compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070141">
<property type="term" value="P:response to UV-A"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033197">
<property type="term" value="P:response to vitamin E"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010165">
<property type="term" value="P:response to X-ray"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00043">
<property type="entry name" value="CYCLIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP02226"/>
<dbReference type="InterPro" id="IPR039361">
<property type="entry name" value="Cyclin"/>
</dbReference>
<dbReference type="InterPro" id="IPR013763">
<property type="entry name" value="Cyclin-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036915">
<property type="entry name" value="Cyclin-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR004367">
<property type="entry name" value="Cyclin_C-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR015451">
<property type="entry name" value="Cyclin_D"/>
</dbReference>
<dbReference type="InterPro" id="IPR006671">
<property type="entry name" value="Cyclin_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10177">
<property type="entry name" value="PTHR10177"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10177:SF67">
<property type="entry name" value="PTHR10177:SF67"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02984">
<property type="entry name" value="Cyclin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00134">
<property type="entry name" value="Cyclin_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00385">
<property type="entry name" value="CYCLIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01332">
<property type="entry name" value="Cyclin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47954">
<property type="entry name" value="SSF47954"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00292">
<property type="entry name" value="CYCLINS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0195">Cyclin</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="G1/S-specific cyclin-D1" id="PRO_0000080430">
<location>
<begin position="1"/>
<end position="295"/>
</location>
</feature>
<feature type="domain" description="Cyclin N-terminal">
<location>
<begin position="28"/>
<end position="152"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="272"/>
<end position="280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 14">
<location>
<position position="286"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="7">
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces ubiquitination and subsequent degradation by the proteasome; when associated with A-288. Abolishes ubiquitination and subsequent degradation following DNA damage." evidence="8 14">
<original>T</original>
<variation>A</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces ubiquitination and subsequent degradation by the proteasome; when associated with A-286." evidence="8">
<original>T</original>
<variation>A</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA52136." ref="3" evidence="21">
<original>N</original>
<variation>G</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; M74092." ref="2" evidence="21">
<original>MP</original>
<variation>IA</variation>
<location>
<begin position="168"/>
<end position="169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA52136." ref="3" evidence="21">
<original>L</original>
<variation>S</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="9"/>
<end position="11"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="21"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="26"/>
<end position="37"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="54"/>
<end position="70"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="77"/>
<end position="89"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="99"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="121"/>
<end position="127"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="128"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="134"/>
<end position="147"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="157"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="172"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="194"/>
<end position="197"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="200"/>
<end position="218"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="220"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="224"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="229"/>
<end position="237"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="241"/>
<end position="255"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="256"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="261"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="292"/>
<end position="294"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W96"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W9Z"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5VZU"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6P8G"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P25322"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10766840"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15241418"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16569215"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18417529"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19124461"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19237565"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19412162"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19917254"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20399237"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21952639"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8302605"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8695815"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9106657"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000305"/>
<sequence length="295" mass="33729" checksum="3CC00C9905F58D3A" modified="1992-03-01" version="1">MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPSMVAAGSVVAAVQGLNLRSPNNFLSYYRLTRFLSRVIKCDPDCLRACQEQIEALLESSLRQAQQNMDPKAAEEEEEEEEEVDLACTPTDVRDVDI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

